Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2003;52:134-139; doi:10.1136/gut.52.1.134
Copyright © 2003 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 2003;52:134-139
© 2003 by Gut

LIVER DISEASE

MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study

F Botta1,*, E Giannini1,*, P Romagnoli1, A Fasoli1, F Malfatti1, B Chiarbonello1, E Testa1, D Risso2, G Colla3, R Testa1

1 Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Italy
2 Department of Health Science, University of Genoa, Genoa, Italy
3 Department of Laboratory Medicine, S Martino Hospital, Genoa, Italy

Correspondence to:
Correspondence to:
Professor R Testa, Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Viale Benedetto XV, No 6, 16132 Genoa, Italy;
rtesta{at}unige.it

Background: Indices for predicting survival are essential for assessing prognosis and assigning priority for liver transplantation in patients with liver cirrhosis. The model for end stage liver disease (MELD) has been proposed as a tool to predict mortality risk in cirrhotic patients. However, this model has not been validated beyond its original setting.

Aim: To evaluate the short and medium term survival prognosis of a European series of cirrhotic patients by means of MELD compared with the Child-Pugh score. We also assessed correlations between the MELD scoring system and the degree of impairment of liver function, as evaluated by the monoethylglycinexylidide (MEGX) test.

Patients and methods: We retrospectively evaluated survival of a cohort of 129 cirrhotic patients with a follow up period of at least one year. The Child-Pugh score was calculated and the MELD score was computed according to the original formula for each patient. All patients had undergone a MEGX test. Multivariate analysis was performed on all variables to identify the parameters independently associated with one year and six month survival. MELD values were correlated with both Child-Pugh scores and MEGX test results.

Results: Thirty one patients died within the first year of follow up. Child-Pugh and MELD scores, and MEGX serum levels were significantly different among patients who survived and those who died. Serum creatinine, international normalised ratio, and MEGX60 were independently associated with six month mortality while the same variables and the presence of ascites were associated with one year mortality. MELD scores showed significant correlations with both MEGX values and Child-Pugh scores.

Conclusions: In a European series of cirrhotic patients the MELD score is an excellent predictor of both short and medium term survival, and performs at least as well as the Child-Pugh score. An increase in MELD score is associated with a decrease in residual liver function.

Keywords: cirrhosis; liver function; ascites; creatinine; Child-Pugh score; MELD; MEGX

Abbreviations: OLT, orthotopic liver transplantation; MEGX, monoethylglycinexylidide; MELD, model for end stage liver disease; TIPSS, transjugular intrahepatic portosystemic stent shunt; INR, international normalised ratio; HCV, hepatitis C virus; HBV, hepatitis B virus; HDV, hepatitis D virus; ROC, receiver operating characteristic; SS, sensitivity; SP, specificity; RR, relative risk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Londono, M.-C., Cardenas, A., Guevara, M., Quinto, L., Heras, D. d. l., Navasa, M., Rimola, A., Garcia-Valdecasas, J.-C., Arroyo, V., Gines, P. (2007). MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 56: 1283-1290 [Abstract] [Full Text]  
  • Lambert, B., Bacher, K., De Keukeleire, K., Smeets, P., Colle, I., Jeong, J. M., Thierens, H., Troisi, R., De Vos, F., Van de Wiele, C. (2005). 188Re-HDD/Lipiodol for Treatment of Hepatocellular Carcinoma: A Feasibility Study in Patients with Advanced Cirrhosis. JNM 46: 1326-1332 [Abstract] [Full Text]  
  • Giannini, E. G., Testa, R., Savarino, V. (2005). Liver enzyme alteration: a guide for clinicians. CMAJ 172: 367-379 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs